Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04276532 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
Track this trialAmended 8 times since 2020-02-17; most recent filed 2026-05-08. Every amendment is listed below.
Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-30.
| NCT Number | NCT04276532 |
| Lead Sponsor | Xiaojun Chen
Collaborators: Fudan University, Tongji Hospital, West China Second University Hospital, Sun Yat-Sen University Cancer Center, Chongqing University Cancer Hospital |
| Conditions | Middle-high Risk Endometrial Cancer, Sentinel Lymph Node Sampling, Prognosis |
| Enrollment | 780 participants |
| Start Date | 2020-02-13 |
| Primary Completion | 2027-01-26 (estimated) |
| Study Completion | 2030-02-12 (estimated) |
| Updated on ClinicalTrials.gov | 2026-05-12 |